- Home
- BCRX vs IQ Comparison
BCRX vs IQ Comparison
Compare BCRX & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- IQ
- Stock Information
- Founded
- BCRX 1986
- IQ 2009
- Country
- BCRX United States
- IQ China
- Employees
- BCRX N/A
- IQ N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- IQ Consumer Electronics/Video Chains
- Sector
- BCRX Health Care
- IQ Consumer Discretionary
- Exchange
- BCRX Nasdaq
- IQ Nasdaq
- Market Cap
- BCRX 1.7B
- IQ 1.6B
- IPO Year
- BCRX 1994
- IQ 2018
- Fundamental
- Price
- BCRX $9.97
- IQ $1.88
- Analyst Decision
- BCRX Buy
- IQ Hold
- Analyst Count
- BCRX 8
- IQ 5
- Target Price
- BCRX $16.75
- IQ $2.60
- AVG Volume (30 Days)
- BCRX 5.9M
- IQ 38.3M
- Earning Date
- BCRX 05-05-2025
- IQ 05-21-2025
- Dividend Yield
- BCRX N/A
- IQ N/A
- EPS Growth
- BCRX N/A
- IQ N/A
- EPS
- BCRX N/A
- IQ 0.11
- Revenue
- BCRX $503,485,000.00
- IQ $4,003,950,893.00
- Revenue This Year
- BCRX $27.64
- IQ $2.67
- Revenue Next Year
- BCRX $13.42
- IQ $3.35
- P/E Ratio
- BCRX N/A
- IQ $18.20
- Revenue Growth
- BCRX 41.67
- IQ N/A
- 52 Week Low
- BCRX $5.06
- IQ $1.50
- 52 Week High
- BCRX $11.11
- IQ $5.80
- Technical
- Relative Strength Index (RSI)
- BCRX 65.89
- IQ 47.68
- Support Level
- BCRX $9.83
- IQ $1.87
- Resistance Level
- BCRX $11.11
- IQ $2.02
- Average True Range (ATR)
- BCRX 0.51
- IQ 0.09
- MACD
- BCRX 0.20
- IQ 0.02
- Stochastic Oscillator
- BCRX 68.33
- IQ 58.82
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.